Startups

Synthetic biology, healthier options, sustainability and digitalisation are big themes for the beauty and food industries this year.

Several new corporate venture units have launched in the past few weeks, showing that big business is still committed to startup investing.

What's going to happen to healthcare startup funding this year? Will the IPO market recover? And what kinds of technologies are on the up? We asked some leading CVCs for their view.

The $275m round, the largest series B for three months, featured several pharmaceutical companies and is part of a thriving environment for gene therapy startups.

Corporations are playing a bigger role in supporting new entrants to the venture industry.

Sustainability and customer experience are on the agenda for transportation CVCs in 2023.

Venture capital has poured into the cleantech sector over the past couple of years. Concerns are growing that startups may not be able to scale into viable companies that generate expected returns.

Take time, focus on quality and internal relationships, make an impact — these are the top resolutions investors have for 2023.

2022 saw a screeching turnaround in market sentiment. How well did corporate investors cope?

The number of $1bn plus CVC funds has increased, but most still work with less than $200m.

Corporate venture teams are pushing portfolio companies to accept more capital during funding rounds to cushion the blow of a stuttering economy.